Plain-English translation of NCT06105515 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a newer, less invasive surgical technique called laparoscopic and endoscopic collaborative surgery (LECS) for patients with advanced stomach cancer who are too ill or frail to undergo standard major surgery. The procedure combines two minimally invasive approaches—one using a camera down your throat (endoscopy) and one using small cuts in your abdomen (laparoscopy)—to remove the cancer while causing less trauma to your body. The goal is to help prevent serious complications like bleeding and blockages while keeping you safer than traditional surgery would.
Many patients with advanced stomach cancer cannot tolerate the demanding standard surgery because of their age or other health conditions. Right now, if surgery or chemotherapy aren't options, these patients have very limited choices. This trial exists to see whether this gentler surgical technique can safely remove cancers and improve quality of life for patients who would otherwise have no treatment options.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will be evaluated by a team of specialists (the multidisciplinary tumor board) to confirm you are a good candidate. If approved, you will receive the laparoscopic and endoscopic collaborative surgery procedure, which is performed under anesthesia and typically involves a shorter recovery than traditional stomach surgery. The study will follow you after the procedure to monitor your safety, recovery, and quality of life.
AI-generated summary from trial data · Jul 9, 2026 · Not medical advice
Sweden